Kritsanee Saramunee

Dr. Kritsanee Saramunee

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Public Health
Verified
Journal Article
Closed access
KSKritsanee Saramunee
Kritsanee Saramunee
JKJ. Krska
J. Krska
AMA. Mackridge
A. Mackridge
JRJ. Richards
J. Richards
SSS. Suttajit
S. Suttajit
PPPenelope Phillips-Howard
Penelope Phillips-Howard

26 May 2023 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
WPWiraphol Phimarn
Wiraphol Phimarn
KSKritsanee Saramunee
Kritsanee Saramunee
ALAreerut Leelathanalerk
Areerut Leelathanalerk
PSPornchanok Srimongkon
Pornchanok Srimongkon
SCSuratchada Chanasopon
Suratchada Chanasopon
ZBZaheer-Ud-Din Babar
Zaheer-Ud-Din Babar

2 September 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
WPWiraphol Phimarn
Wiraphol Phimarn
PKPongsatorn Kaewphila
Pongsatorn Kaewphila
SSSiritree Suttajit
Siritree Suttajit
KSKritsanee Saramunee
Kritsanee Saramunee
Depressive symptom among adolescent is prevalent but advisory service for this symptom is limited, particularly in university. (1) To identify depressive students in health science faculties, (2) To evaluate the consequence of depression advisory service by community pharmacist, compared between a group counseling and an individual one. A two-phase study was designed—a cross-sectional study followed by an experimental study. Health science students were screened by CES-D questionnaire. The prevalence and predictors of depressed mood were determined. Depressive students were then invited to the experimental study. Participants were assigned into 2 groups, by stratified random sampling, and followed up for 16 weeks. Group 1 received a group counselling, group 2 received an individual counselling from a trained pharmacist. Outcomes measured were the CES-D score and quality of life. The prevalence of depressed mood students was 13.7 % (195/1421). Students in year 2nd and year 3rd, nursing and medicine students, and GPA were strongly associated with the CES-D score (P < 0.05). Sixty-eight depressive students were assigned into the experiment. The CES-D scores of both groups were significantly reduced from the baseline (P < 0.001). The post-test score of group 2 was lower than group 1 (17.7 ± 4.5 vs 20.1 ± 4.6, P = 0.038). At week 16, both counselling types significantly increased mean score of physical health (P < 0.001) whereas score of mental health was increased significantly only by the individual counselling, from 37.9 ± 9.9 to 43.1 ± 8.4 (P = 0.036). Depressive symptom among health science students is considerably high. Year of study, faculty and GPA are significant predictors of this disorder. Trained community pharmacists can effectively screen and provide advisory service. Individual counseling is more effective than using group advice.

1 January 2022 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
KSKritsanee Saramunee
Kritsanee Saramunee

WPWiraphol Phimarn
Wiraphol Phimarn
RSRotjanawat Sakhancord
Rotjanawat Sakhancord
PPPeerasaran Paitoon
Peerasaran Paitoon
KSKritsanee Saramunee
Kritsanee Saramunee
Bunleu SungthongBunleu Sungthong
Bunleu Sungthong
Background: Although varenicline has been used for alcohol dependence (AD) treatment, its efficacy for this condition remains controversial. Aims: This systematic review and meta-analysis of randomized controlled trials (RCTs) assesses the efficacy and safety of varenicline in patients with AD. Methods: PubMed, Cochrane Library, ScienceDirect, Web of Science, and ThaiLis were systematically searched. RCTs investigating the efficacy and safety of varenicline in patients with AD were included. Study selection, data extraction, and quality assessment were independently performed by two authors. The Jadad score and Cochrane risk of bias were used to assess the quality of the included studies. Heterogeneity was assessed using I2 and chi-squared tests. Results: Twenty-two high-quality RCTs on 1421 participants were included. Varenicline significantly reduced alcohol-related outcomes compared with placebo based on percentage of abstinent days (standardized mean difference [SMD] 4.20 days; 95% confidence interval [CI]: 0.21, 8.19; p = 0.04), drinks per day (SMD −0.23 drinks; 95% CI: −0.43, −0.04; p = 0.02), drinks per drinking day (SMD −0.24 drinks; 95% CI: −0.44, −0.05; p = 0.01), craving assessed using the Penn alcohol craving scale (SMD −0.35; 95% CI: −0.59, −0.12; p = 0.003), and craving assessed using the alcohol urge questionnaire (SMD −1.41; 95% CI: −2.12, −0.71; p < 0.0001). However, there were no significant effects on abstinence rate, percentage of drinking days, percentage of heavy drinking days, alcohol intoxication, or drug compliance. Serious side effects were not observed in the varenicline or placebo groups. Conclusion: Our results indicated that AD patients treated with varenicline showed improvement in percentage of very heavy drinking days, percentage of abstinent days, drinks per day, drinks per drinking day, and craving. However, well-designed RCTs with a large sample size and long duration on varenicline treatment in AD remain warranted to confirm our findings.

27 October 2020 in Primary Health Care Research & Development
Verified
Journal Article
Open access
PDF file
JSJumnean Somanawat
Jumnean Somanawat
KSKritsanee Saramunee
Kritsanee Saramunee
SCSuratchada Chanasopon
Suratchada Chanasopon
This study aimed to describe the process of care, assess the quality of care based on defined indicators, and identify challenges associated with providing diabetes care via sub-district health promotion hospital (SHPH) facilities in Thailand. Primary care policy has directed that diabetes care be delivered via SHPH in order to reduce hospital congestion and minimize travel costs for patients. Limited data is available regarding the structure for providing care. Likewise, barriers to delivery of optimal care have not been well defined, especially from the perspective of health care providers. This study employed mixed-methods research, which included semi-structured interviews to gain insights into the current diabetes care process, a descriptive study to evaluate quality of care, and use of a focus group to identify challenges associated with delivery of diabetic care via SHPH. Diabetes care processes in primary care included multiple steps and involved collaboration between various health care providers at both the hospital and SHPH. Four process indicators and one outcome had been achieved but performance of other indicators was apparently low. Three factors were found to pose challenges to providing this service: the resources of the health service, the delivery of services, and patient factors. SHPH require additional support, particularly in the areas of primary care workforce, finance, medical device procurement, and patient information systems. While delivery of diabetes care via primary care centers has been well established in Thailand, regional differences in the quality of care persist. Additional support is required to strengthen the primary care system nationwide.